Tumor Microenvironment Program, Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA.
Biol Pharm Bull. 2012;35(10):1626-32. doi: 10.1248/bpb.b12-00395.
Although numerous carbohydrates play significant roles in mammalian cells, development of carbohydrate-based reagents and therapeutics are hampered by the technical difficulty of chemically synthesizing complex carbohydrate structures. Use of carbohydrate mimetic peptides circumvents this difficulty, as short peptide can be easily synthesized and modified. We as well as others identified carbohydrate mimetic peptides by screening peptide displaying phage library using anti-carbohydrate antibodies and lectins. This review introduces our experiences with I-peptide that was used for identification of new carbohydrate binding receptor expressed in the lung endothelial cells, and those with IF7 peptide that can be used as a therapeutic against malignant tumors.
尽管许多碳水化合物在哺乳动物细胞中发挥着重要作用,但由于化学合成复杂碳水化合物结构的技术难度,基于碳水化合物的试剂和疗法的发展受到了阻碍。使用碳水化合物模拟肽可以克服这一困难,因为短肽可以很容易地合成和修饰。我们和其他人通过使用抗碳水化合物抗体和凝集素筛选噬菌体展示文库,鉴定了碳水化合物模拟肽。这篇综述介绍了我们使用 I-肽来鉴定在肺内皮细胞中表达的新型碳水化合物结合受体的经验,以及使用 IF7 肽作为治疗恶性肿瘤的经验。